Core Insights - Avantor, Inc. reported a return to growth in Q4 2024, with sequential and year-over-year increases in adjusted EBITDA margin, adjusted EPS, and free cash flow conversion [2][3] - The company experienced a net sales decrease of 2% in Q4 2024 compared to Q4 2023, but achieved 1% organic growth [4][9] - For the full year 2024, net sales were $6,783.6 million, a decrease of 3% compared to 2023, with a 2% organic decline [7][8] Financial Performance - Q4 2024 net income rose to $500.4 million from $98.5 million in Q4 2023, with an adjusted net income of $183.9 million compared to $166.7 million in the prior period [5][9] - The adjusted EBITDA for Q4 2024 was $307.7 million, with an adjusted EBITDA margin of 18.2% [5][9] - For the full year 2024, net income increased to $711.5 million from $321.1 million in 2023, with an adjusted EBITDA of $1,198.8 million and an adjusted EBITDA margin of 17.7% [8][9] Cash Flow and Leverage - Operating cash flow for Q4 2024 was $173.3 million, while free cash flow was $222.1 million [6][9] - For the full year 2024, operating cash flow was $840.8 million, and free cash flow was $768.3 million [10][9] - The adjusted net leverage ratio was 3.2x as of December 31, 2024 [10] Segment Performance - The bioprocessing platform grew in high-single digits, indicating strong performance in that segment [2] - The company’s new operating model and cost transformation program are ahead of schedule, contributing to improved efficiency [3]

Core Viewpoint - Avantor, Inc. will release its fourth quarter and full year 2024 financial results on February 7, 2025, before market opens, followed by a conference call at 8:00 a.m. Eastern Standard Time to discuss the results [1] Company Overview - Avantor is a leading life science tools company and a global provider of mission-critical products and services to the life sciences and advanced technology industries [3] - The company collaborates with customers throughout the scientific journey to enable breakthroughs in medicine, healthcare, and technology [3] - Avantor's portfolio is utilized in nearly every stage of significant research, development, and production activities at over 300,000 customer locations across 180 countries [3]

Company Overview - Avantor is a leading global provider of mission-critical products and services to the life sciences and advanced technology industries [3] - The company supports customers at every stage of the scientific journey, enabling breakthroughs in medicine, healthcare, and technology [3] - Avantor's portfolio is utilized in virtually every stage of research, development, and production activities at over 300,000 customer locations across 180 countries [3] Upcoming Event - Michael Stubblefield, President and CEO of Avantor, will present at the 43rd Annual J P Morgan Healthcare Conference on January 15, 2025, at 8:15 a m Pacific Standard Time [1] - The presentation will take place at The Westin St Francis Hotel in San Francisco [1] Investor Relations - A live audio webcast of the presentation will be available on Avantor's website under the Investor section [2] - The webcast replay will be accessible for 30 days following the event [2]

Avantor (NYSE: AVTR ) is a global leader of critical products and services with world-class distribution positioned to grow mid-single digits over the long term. Industry headwinds from destocking, the IRA bill, and normalization of growth have weighed on the stock price, drivingAnalyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses m ...

Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Avantor, Inc. (AVTR) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The proven Zacks Rank puts an emphasis on earnings ...

RADNOR, Pa., Nov. 20, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that President and CEO, Michael Stubblefield, will be participating in a fireside chat at the Evercore ISI HealthCONx Conference in Coral Gables, Florida on Tuesday, December 3, at 9:10 a.m. Eastern Standard Time.To hear a live audio webcast of the session, visit Events & Presentations in the ...

Avantor's new Bridgewater Innovation Center spans 60,000 square feet, doubling its previous laboratory and pilot plant capacity. Purpose-designed for collaborative work, the center houses spaces for upstream and downstream process development, dedicated analytical testing labs, and a viral vector laboratory. An expanded pilot plant supports scale-up simulations, enabling rapid customization across the entire bioprocessing workflow. "Our new Bridgewater Innovation Center is twice the size of our previous fac ...

Investors looking for stocks in the Medical Services sector might want to consider either Pediatrix Medical Group (MD) or Avantor, Inc. (AVTR) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank puts an empha ...

RADNOR, Pa., Nov. 6, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that the Avantor Board of Directors has appointed Dame Louise Makin, DBE, Ph.D., as a director with an initial term expiring at Avantor's 2025 Annual Meeting of Stockholders. The appointment of Dame Louise as an independent director fills a vacant board seat.Dame Louise brings a wealth of lead ...

(Vavantor Q3 2024 Earnings EARNINGS PRESENTATION October 25, 2024 AVTR LISTED NYSE Disclaimer This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and are subject to the safe harbor created thereby under the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this presentation are forward-looking statements. Forward-looking ...